We and others have recently found that GRB7 and its variant, GRB7v, are frequently upregulated in ovarian cancers and are able to enhance cell proliferation, migration/invasion through activating ERK signaling pathway [12], [36], [37]. Here, GRB7 is linked to ovarian cancer.